Berkeley Lights Stock
Cell Manipulation for Personalized Therapies
Sign up today and learn more about Berkeley Lights Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Berkeley Lights Stock
Berkeley Lights, Inc. (BLI) is a platform for single cell manipulation that allows for researchers to analyze cells. It aims to provide platforms that automate the manipulation and analysis of cells. The Beacon platform, the company's flagship product, is suited for cell line development, antibody discovery, gene editing, and antibody engineering workflows. The platform uses optofluidics and light-based technology to automate the work of cloning, culturing and sorting specific cells from biological samples. By automating these processes, they aim to cut the time and human labor needed to develop cell lines, discover and engineer antibodies, and do gene editing.
The company was founded in 2011 in Emeryville, California.
Chief Executive Officer
Chief Financial Officer
Chief Scientific Officer
Kevin Chapman, Ph.D.
Chief Technology Officer
Keith Breinlinger, Ph.D.
Vice President, People Operations
John Proctor, Ph.D.
SVP, Global Sales